HighTower Advisors »

Recursion Pharmaceuticals shares owned by HighTower Advisors

Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Recursion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Recursion Pharmaceuticals held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recursion Pharmaceuticals by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $278k 37k 7.47
2024-03-31 $129k 13k 9.79

More positions owned by HighTower Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Exxon Mobil Corporation (XOM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Johnson & Johnson (JNJ)

View all positions for HighTower Advisors

Top funds holding Recursion Pharmaceuticals

ARK Investment Management
Baillie Gifford & Co
Vanguard Group
BlackRock
BlackRock
RA Capital Management
Mubadala Investment Co PJSC
Kinnevik AB
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
State Street Corporation
MIC Capital Management UK
Nvidia Corp
Geode Capital Management
Exor Investments

View all funds holding Recursion Pharmaceuticals